Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 4,460 3,172 15,498 11,178 Share-based compensation 4,262 3,424 16,690 14,027 Deferred income taxes (1,332) (1,161) (4,738) 131 Impairment charges for facilities consolidation ...
Non-GAAP adjustments to net income (1.89 ) 0.05 (1.19 ) 1.66 Non-GAAP net income per share, basic $ 0.93 $ 0.90 $ 4.44 $ 1.74 Net income per share, diluted: GAAP net income per share, diluted $ 2.79 $ 0.83 $ 5.55 $ 0.07 Non-GAAP adjustments to net income (1.87 ) 0.05 (...
The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this...
Total debt and finance lease obligations of $20.1 billion at year end Full Year 2023 Adjusted Financial Results Operating revenue of $54.7 billion, 20 percent higher than the full year 2022 Operating income of $6.3 billion with an operating margin of 11.6 percent Pre...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Highlights Fourth quarter revenue was $10
and/or rent an apartment in college, you won’t be getting any of those things if your credit score is too low. Knowing your score means you can make adjustments now that will set you up for financial success later.Credit Karmais a great place to start for free credit reports, monitorin...
“Our accelerated performance and commitment to strengthening the balance sheet have allowed us to reduce both leverage and cost of capital, consistent with our goal of achieving investment grade metrics, and we continue to expect our leverage to be below 3.5x ...
Profitability improvement program: In January 2024, the Company shared a series of actions to improve its profitability by $645 million by year end 2025 in comparison to the base year 2023. Through the fourth quarter 2024, the Company had implemented numerous improvements to exceed its ...
financial closing procedures, final audit adjustments and other developments may arise that would requireExelixisto make material adjustments to the preliminary financial results included in this press release. Therefore, the preliminary financial results included in this press release may differ, perhaps ...
"Our accelerated performance and commitment to strengthening the balance sheet have allowed us to reduce both leverage and cost of capital, consistent with our goal of achieving investment grade metrics, and we continue to expect our leverage to be below 3.5x by year end," saidN...